Ampel BioSolutions Identifies Novel Lupus Treatments And Targets

Virginia researchers and founders of AMPEL BioSolutions, Drs. Amrie Grammer and Peter Lipsky delivered the results of a year-long Lupus Drug Repositioning Initiative this week in Boston. The Alliance for Lupus Research (ALR), the Lupus Research Institute (LRI) and AMPEL gathered with scientists at a key meeting of the American College of Rheumatology to launch the Lupus Clinical Investigators Network (LuCIN) of the LRxL-STAT Lupus Drug Repositioning Initiative.

Read full press release…